Updated 19 September 2019


About the network

Disease-specific clinical trials networks: the example of cystic fibrosis
De Boeck K., Bulteel V., Fajac I.
Eur J Pediatr. 2016 Mar 15. [Epub ahead of print]
http://link.springer.com/article/10.1007%2Fs00431-016-2712-z

The European Cystic Fibrosis Society–Clinical Trials Network: an international network to optimize clinical research for a rare disease
I. Fajac, V. Bulteel, C. Castellani, T. Lee, N. Derichs, P. Drevinek, L. Pereira, C. Dubois, A. Reimann, K. De Boeck
Clin Invest (2013) 3(10), 921–926

Developing an international network for clinical research: the European Cystic Fibrosis Society – Clinical Trials Network experience
V. Bulteel, C. Castellani, S. Conway, C. Dubois, I. Fajac, L. Pereira, A.Reimann, K. De Boeck
Clin Invest (2011) 1(6), 775–780

Guideline on the design and conduct of cystic fibrosis clinical trials:
The European Cystic Fibrosis Society–Clinical Trial Network (ECFS-CTN)

K. De Boeck, V. Bulteel, H. Tiddens, T. Wagner, I. Fajac, S. Conway, F. Dufour, . Smyth, T. Lee, I. Sermet, B. Kassai-Koupai, S. Elborn on behalf of all ECFSCTN network partners
J Cyst Fibros Volume 9 Suppl 3 (2010) S58–S65

About endpoints for clinical trials in cystic fibrosis


Guidance for computed tomography (CT) imaging of the lungs for patients with cystic fibrosis (CF) in research studies

Joint effort by the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) and the Cystic Fibrosis Foundation-Therapeutics Development Network (CFF-TDN) National Resource Centers Working Group

Marcel van Straten, Alan S. Brody, Caroline Ernst, R. Paul Guillerman, Harm A.W.M. Tiddens, Scott K. Nagle 
Journal of Cystic Fibrosis 2019 https://doi.org/10.1016/j.jcf.2019.09.001


A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials
G.Taccetti, M.Denton, K.Hayes, P.Drevinek, I.Sermet-Gaudelus
ECFS-CTN Microbiology Group
Journal of Cystic Fibrosis 2019 https://doi.org/10.1016/j.jcf.2019.08.014


Lung clearance index: Evidence for use in clinical trials in cystic fibrosis. 
Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HG, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K; On behalf of the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.
J Cyst Fibros 2014; 13(2): 123-138
 
Clinimetric properties of broncho-alveolar lavage inflammatory markers in cystic fibrosis
Fayon M, Kent L, Bui S, Dupont L, Sermet I; European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.
Eur Respir J 2014; 43(2): 610-26
 
CFTR biomarkers: time for promotion to surrogate end-point?
K. De Boeck, L. Kent, J. Davies, N. Derichs, M. Amaral, S.M. Rowe, P. Middleton, H. de Jonge, I. Bronsveld, M. Wilschanski, P. Melotti, I. Danner-Boucher, S. Boerner, I. Fajac, K. Southern, R.A. de Nooijer, A. Bot, Y. de Rijke, E. de Wachter, T. Leal, F. Vermeulen, M.J. Hug, G. Rault, T. Nguyen-Khoa, C. Barreto, M. Proesmans and I. Sermet-Gaudelus on behalf of the European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee
Eur Respir J 2013; 41: 203–216


Other

A new Clinical Trials Directive to boost academic trials?
De Boeck K, Tiddens H, Elborn S, Fajac I; European Cystic Fibrosis Society (ECFS) and the ECFS Clinical Trial Network.
Lancet Respir Med 2013; 1(2): 99-101